ストックスクリーナーアプリを入手
4.33
1.37%
-0.06
プレマーケット:
4.37
0.04
+0.92%
前日終値:
$4.39
開ける：
$4.34
24時間の取引高:
162.20K
Relative Volume:
0.70
時価総額：
$133.26M
収益：
$71.61M
当期純損益:
$-48.59M
株価収益率:
-2.4729
EPS:
-1.751
ネットキャッシュフロー:
$-32.88M
1週間 パフォーマンス:
-5.46%
1か月 パフォーマンス:
+2.36%
6か月 パフォーマンス:
+17.03%
1年 パフォーマンス:
-24.96%
1日の値動き範囲:
$4.2301
$4.50
1週間の範囲:
$4.13
$4.67
52週間の値動き範囲:
$3.22
$7.12
Avita Medical Inc Stock (RCEL) Company Profile
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.33 | 135.11M | 71.61M | -48.59M | -32.88M | -1.751 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-05 | 開始されました | Northland Capital | Outperform |
| 2025-11-20 | アップグレード | BTIG Research | Sell → Neutral |
| 2025-08-08 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical (RCEL) Gains 2.2% as Shares Test Key Resistance at $4.81Composite Profile - Newser
Avita Medical Stock Price Forecast. Should You Buy RCEL? - StockInvest.us
Avita Medical Q1 earnings call highlights - MSN
Morgans says these ASX shares could rise 12% to 20% - MSN
Insider Buying: David O'Toole Acquires Shares of AVITA Medical I - GuruFocus
AVITA Medical (RCEL) CFO adds 2,000 shares in open-market buy - Stock Titan
AVITA Medical (RCEL) CFO adds 2,000 shares in open-market purchase - Stock Titan
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical to Host Investor Webinar Briefing | Associated Press | syndication news - Enidnews.com
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2026 Earnings Call Transcript - Insider Monkey
AVITA Medical Q1 2026 earnings preview - MSN
RCEL Upgraded by Lake Street -- Price Target Raised to $6.00 - GuruFocus
Avita Medical Raised to Buy From Hold by Lake Street - Moomoo
Avita Medical, Inc. Stock 12‑Month Price Target Raised to $6.99, Implies 60% Upside - TradingView
Avita (RCEL) Q1 2026 Earnings Call Transcript - The Globe and Mail
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $5.5 - Moomoo
AVITA Medical, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Avita reaffirms $80M-$85M 2026 revenue guidance as RECELL reimbursement normalizes and Cohealyx data targets faster graft readiness - MSN
Lake Street upgrades AVITA Medical (RCEL) - MSN
RCEL Reports Q1 Revenue Below Expectations - GuruFocus
RCEL Revenue Forecast for FY26 Indicates Strong Growth Potential - GuruFocus
Is AVITA Medical (RCEL) a Value Trap Despite Q1 2026 Revenue Bea - GuruFocus
AVITA Medical Inc (AVHHL) Q1 2026 Earnings Call Highlights: Reve - GuruFocus
Avita Medical Posts Narrower Q1 Loss, Higher Revenue; Reaffirms Full-Year 2026 Outlook - Moomoo
AVITA Medical's (ASX:AVH) First Quarter 2026 Results and Strategic Reset Explained - Kalkine
Avita Medical Q1 Earnings Call Highlights - MarketBeat
AVITA Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
RCEL: Revenue rose 4% year-over-year to $19.3M, with improved margins and reaffirmed guidance - TradingView
Avita Medical earnings missed by $0.06, revenue topped estimates - Investing.com Canada
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
AVITA Medical Reports First Quarter 2026 Financial Results - Investing News Network
Avita Medical stock (US0301011039): Q1 2026 results and revenue details - AD HOC NEWS
RCEL: Q1 2026 delivered revenue growth, improved margins, and strong clinical momentum for new products - TradingView
Q1 2026 AVITA Medical Inc Earnings Call Transcript - GuruFocus
AVITA Medical (RCEL) posts Q1 2026 loss, adds new credit line and BARDA deal - Stock Titan
AVITA Medical (RCEL) Q1 2026 revenue rises 4% as losses narrow and 2026 outlook held - Stock Titan
AVITA Medical, Inc. Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
AVITA Medical Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Avita Medical stock (US0301011039): Shares surged 7.75% in July 2025 - AD HOC NEWS
TradingKey - tradingkey.com
Avita Medical Inc. (NASDAQ:RCEL) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
AVITA Medical Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Avita Medical (RCEL) Expected to Announce Earnings on Thursday - MarketBeat
AVITA Medical appoints Cary Vance as permanent CEO - MSN
AVITA Medical Appoints Cary Vance as Permanent CEO and Jan Stern Reed as Board Chair to Drive Growth in Acute Wound Care Solutions - Minichart
Avita Medical Names Cary Vance Permanent CEO, Reshapes Board - The Globe and Mail
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen - MarketBeat
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
0.59%
1.94%
大文字化:
|
ボリューム (24 時間):